In line with this commitment, NexBiolinea has expanded its ENAC accreditation scope under the UNE-EN ISO/IEC 17025 standard, incorporating new accredited tests within our water microbiology and food microbiology areas.

This expansion represents another step forward in our strategy of continuous improvement, technical investment and consolidation as a laboratory specialized in environmental health, food safety and microbiological control for the tourism and hospitality sector.

What does it mean for a laboratory to be accredited by ENAC?

The Spanish National Accreditation Body (ENAC) is the organization responsible in Spain for assessing and recognizing the technical competence of laboratories according to international standards.

For testing laboratories, accreditation is granted under the UNE-EN ISO/IEC 17025 standard, the international benchmark that establishes the requirements laboratories must meet in order to demonstrate:

• technical competence,
• analytical reliability,
• traceability of results,
• internal quality control,
• method validation,
• equipment calibration,
• staff qualification,
• and assurance of impartiality.

In other words, working with an accredited laboratory means working with technically validated and internationally recognized results.

For sensitive sectors such as hospitality, tourism, the food industry or the management of health-risk facilities, this aspect is essential.

New accredited tests incorporated by NexBiolinea

As part of this accreditation scope expansion, NexBiolinea has incorporated new accredited tests of major sanitary and operational relevance.

Among them are:

Pseudomonas aeruginosa in water

The detection of Pseudomonas aeruginosa is one of the most important microbiological controls in certain aquatic and sanitary installations.

This opportunistic microorganism is associated with health risks in water systems and humid environments, particularly in facilities with high user exposure.

The accreditation of this test strengthens our analytical capabilities in areas such as:

• microbiological water control,
• swimming pools and spas,
• hotel facilities,
• drinking water,
• and sanitary prevention programs.

Escherichia coli in food

The accredited incorporation of Escherichia coli testing in food represents a significant advancement within our food microbiology services.

This parameter is one of the main microbiological indicators of hygiene and food safety and plays a key role in:

• HACCP controls,
• process validation,
• hygienic-sanitary control,
• incident investigation,
• and verification of good handling practices.

In an environment where food safety has an increasingly important operational and reputational impact, having accredited tests provides significant added value for both hotel establishments and food business operators.

Total coliforms in water

This expansion also includes the accredited testing of total coliforms in water, a parameter widely used as a microbiological indicator of sanitary quality and hygienic control.

These analyses are essential for:

• verifying the microbiological quality of water,
• detecting potential contamination,
• evaluating treatment effectiveness,
• and ensuring compliance with sanitary and operational requirements.

Much more than a certification

ENAC accreditation should not be understood merely as a documentary distinction.

Behind every accreditation there is a complete technical system based on:

• validated procedures,
• periodic audits,
• quality controls,
• continuous evaluation,
• specialized training,
• equipment maintenance,
• metrological traceability,
• and independent supervision.

For this reason, expanding an accredited scope requires significant technical and human effort from the laboratory team.

Commitment to continuous improvement and technical innovation

This expansion also reflects NexBiolinea’s commitment to continuous technical development in strategic areas related to:

• water microbiology,
• food safety,
• environmental health,
• Legionella prevention,
• sanitary quality,
• technical auditing,
• and risk management in tourism facilities.

Our objective is to continue providing clients and partners with increasingly robust and reliable analytical tools aligned with the most demanding international standards.

The value of the team

No accreditation would be possible without the human team behind the laboratory.

The expansion of our ENAC accreditation scope is the result of the daily commitment of our professionals to scientific rigor, analytical quality and continuous improvement.

A collective effort that allows us to continue moving forward and strengthening the trust placed in us by clients, hotel chains, tour operators and companies from multiple sectors.

Further information

The updated ENAC accreditation scope of NexBiolinea can be consulted at the following link:

https://www.enac.es/documents/7020/95ac5403-a279-4db3-8a0f-a59ca246697c

At NexBiolinea, we continue to expand and get closer to our clients. Since September 2025, we are proud to operate a new laboratory on the island of Gran Canaria.

This new facility allows us to offer faster, more efficient, and locally focused services to our clients across the Canary Islands—one of Europe’s most important tourism destinations and a strategic region for our company.

The Canary Islands laboratory has been designed to meet the specific needs of the hotel and tourism sector of the archipelago. It features advanced technology for water, food, and surface analysis, and is fully connected to our digital ecosystem BioAuditApp.

“The Canary Islands represent a strategic point for NexBiolinea. With this new laboratory, we strengthen our presence in one of the most relevant tourism destinations worldwide and reaffirm our commitment to public health, sustainability, and technical excellence.”
— Pau Crespi, CEO of NexBiolinea.

With this new opening, NexBiolinea adds another operational base in Spain, consolidating a network of laboratories across Mallorca, the Canary Islands, Mexico, and the Dominican Republic—all united by one mission: to ensure safer, healthier, and more sustainable destinations.

At NexBiolinea, we continue to grow and strengthen our international presence with the inauguration of two new laboratories in the Caribbean, located in Punta Cana (Dominican Republic) and Cancún (Mexico).

These new facilities allow us to bring our analytical, consultancy, and training services closer to our clients, offering a faster, local, and more customized response to the needs of hotels and tour operators in the region.

Both laboratories are equipped with cutting-edge technology for the analysis of water, food, and surfaces, and are fully integrated within our digital ecosystem BioAuditApp, which enables real-time management of audits, analytical results, and corrective action plans.

Beyond expanding our technical capacity, these openings reinforce our mission to deliver scientific, rigorous, and innovative solutions that contribute to a safer, more sustainable, and evidence-based tourism industry.

“These new laboratories reflect our way of working: proximity to our clients, continuous innovation, and an unwavering commitment to quality. It marks another step forward in our global vision of protecting public health in tourism destinations,”
— Pau Crespi, CEO of NexBiolinea.

“We are very proud of the team that made this project possible, and of continuing to combine knowledge and technology in support of a more responsible tourism model,”
— Dr. Sebastià Crespí, President and Scientific Director of NexBiolinea.

With these inaugurations, NexBiolinea now operates laboratories in Spain, the Dominican Republic, and Mexico, consolidating its position as an international benchmark in environmental health, food safety, and sustainability applied to the tourism sector.

Among his most notable contributions:

With more than 40 years of experience and projects in over 40 countries, Dr. Crespí has been a key figure in positioning the Balearic Islands as a global benchmark for safe, healthy, and sustainable tourism.

• Co-author of the ABTA (UK) Guide to Good Practices for preventing illness in tourist environments.
• Co-author of the European Centre for Disease Prevention and Control (ECDC) guidelines for Legionella prevention.
• Lead author of the World Health Organization (WHO) guidelines for hotel reopening following the COVID-19 pandemic — a pivotal tool that helped restore global confidence in destinations like the Balearic Islands.

This recognition holds special significance in 2025, as NexBiolinea celebrates its 25th anniversary, reinforcing our shared commitment — between science, business and institutions — to building a safer, more innovative and resilient tourism model.

At NexBiolinea, we are deeply proud of this recognition and sincerely thank all individuals, institutions, and organisations that supported this well-deserved nomination.

This initiative reinforces our commitment to sustainability NexBiolinea, embedding it from the ground up — through people and their working environment.

The course also introduced the procedure for the recognition of professional competencies, an official way to validate work experience and skills acquired outside the formal education system. Another step forward in developing talent within the NexBiolinea sustainability model.

This training activity is part of the 2023 grant call regulated by Order EFP/624/2023 and is funded by the European Union – NextGenerationEU, under the Recovery, Transformation and Resilience Plan.

At NexBiolinea, we believe sustainability is not a choice — it’s the path to a more conscious, efficient, and environmentally respectful tourism model.

Beyond commemorating 25 years of our company’s journey, this event paid tribute to the professional path of those who have led this project for over two decades, including Beatriz Santandreu, Jorge del Barrio, Andrés Bedoya, Marga Cifre, Ana Mª García, Ana Flavia, and Magdalena Bennassar. A heartfelt tribute was also given to Dr. Sebastián Crespí, founder of NEXBIOLINEA, for his more than 40 years of professional dedication.

Brand Unification: The New NEXBIOLINEA Is Born

A key milestone was presented during the event: the unification of all our brands under one single commercial identity, NEXBIOLINEA. This change symbolizes our commitment to consolidating our value proposition, simplifying our presence in the market, and strengthening our connection with all stakeholders through a single voice and vision.

Words from Pau Crespí, CEO of NEXBIOLINEA

“Celebrating 25 years is something to be proud of, but even more important is looking toward the future with ambition. We have witnessed constant transformation, and today we begin a new phase with the opening of new laboratories in Mexico, the Dominican Republic, and the Canary Islands. These projects reinforce our international commitment and our drive to continue leading through scientific excellence, without ever losing sight of people and clients.”

Words from Dr. Sebastián Crespí, President and Scientific Director

“NEXBIOLINEA has grown with strong and clear values: Integrity, Scientific Rigor, Passion, and Customer Orientation. These principles have guided every decision, every project, and every relationship built over the past 25 years. What we celebrate today is also the trust our clients and partners have placed in us, and our ongoing commitment to respond with the same dedication and professionalism that brought us here.”

Thank You, NEXBIOLINEA Team

We extend our deepest gratitude to the entire NEXBIOLINEA team — the true engine behind this journey. Your professionalism, dedication, and commitment have been essential in reaching this milestone. This anniversary not only honors our past, but also sets a clear intention for the path we wish to walk together in the years to come.

Why NEXBIOLINEA?

Throughout our history, we have worked with two brands that have been benchmarks in their respective fields. Biolinea has distinguished itself by its focus on health and the environment, while ATA has brought a technical and specialized vision in water hygiene and advanced technological solutions. However, operating with two names created challenges in our communication and positioning.

NEXBIOLINEA arises as a strategic response to consolidate our value proposition under a unique and differentiated brand.

• “Nex” stands for connection, evolution and innovation, reflecting our commitment to technology and applied knowledge.
• “Biolinea” maintains our essence, recalling our origin and commitment to public health and the environment.

One Brand, One Unified Vision

With NEXBIOLINEA, we simplify our identity and strengthen our positioning in an increasingly demanding market. This transition allows us to:

✅ Greater clarity: a single name that encompasses our entire service offering.

✅ Greater competitiveness: We consolidate our leading position in consulting, laboratory and innovative solutions.

✅ International presence: A strong and coherent identity that conveys confidence and professionalism.

But this transformation also responds to the need to integrate new areas that we have developed in recent years:

🔹 Sustainability area: Our commitment to sustainability responds to the urgency of offering innovative solutions that minimize the environmental impact of our clients’ operations. We believe in a science applied to conservation and in strategies based on circular economy and resource efficiency.

🔹 Specialized training area: We have consolidated a training area designed to train professionals and companies in health, safety and environmental management. Our goal is to share knowledge and prepare teams to meet the challenges of the sector with solvency.

This change is not a break with the past, but a natural evolution that drives us to continue offering comprehensive and cutting-edge solutions to our customers.

The Future of Consulting and Innovation is  Here

At NEXBIOLINEA, we remain committed to quality, science and technical excellence. Our new identity reflects not only who we are, but also our vision of the future: a restless, innovative and constantly evolving team.Join us in this new phase. Welcome to NEXBIOLINEA.

Values that set us apart

Since our beginning, we have maintained two fundamental pillars:

✅ Scientific rigor and cutting-edge knowledge: we strive to always be one step ahead, applying the best practices and technologies to offer reliable and effective solutions.

✅ Integrity and professional ethics: Every decision, every strategy and every action is guided by solid principles that guarantee transparency, trust and quality.

Our Commitment to Customers

What really sets us apart is our customer focus. More than service providers, we are strategic partners, offering:

• Rigorous assessments to ensure safety and regulatory compliance.
• Customized solutions, adapted to each sector and specific need.
• Continuous support, with an expert team always available to advise and improve processes.

The impact of our solutions extends beyond each client, generating a positive change in society. Through our work, we contribute to safer, more sustainable and efficient environments, improving the quality of life and competitiveness of the sector.

Strategic Plan 2025-2030: People, Planet, Performance

To continue growing with impact, we have designed a five-year strategic plan based on the three “P’s”:

🌍 People: We believe in developing talent and empowering the professional growth of every member of our organization and our clients.

♻️ Planet: We are committed to sustainability and the circular economy, helping companies to minimize their environmental impact and optimize resources.

📈 Performance: We continuously innovate to improve the efficiency, quality and competitiveness of our services.

Growing by making it grow

The motto that drives us is clear: “Growing by making it grow”. We seek not only business success, but also to bring value to our customers, partners and the industry in general. This is our commitment: to grow with purpose, innovate with responsibility and transform the industry with sustainable, high-impact solutions.

Thank you for being part of this journey. Together, we are building the future of NEXBIOLINEA.